FDA Approved: ZOLEDRONIC ACID — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves Hikma Pharmaceuticals USA Inc.'s original application for a generic zoledronic acid injectable product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases From Solid Tumors
• Hypercalcemia of Malignancy
• Multiple Myeloma
• Osteoporosis
• Paget Disease of Bone

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

ORIG AP for ZOLEDRONIC ACID (ZOLEDRONIC ACID)